accp
annual
abstract
exclud
origin
publish
issu
miss
abstract
ribavirin
plu
interferon
manag
middl
east
respiratori
syndrom
coronaviru
histor
control
studi
patient
eyad
alkhadhairi
sulaiman
alzubairi
pharmd
mba
bcp
bcop
maram
abuzaid
ms
abdulkhaliq
alsalman
rph
msc
colleg
pharmaci
northern
border
univers
rafha
saudi
arabia
clinic
pharmaci
servic
john
hopkin
aramco
healthcar
dhahran
saudi
arabia
princ
moham
bin
abdulaziz
hospit
riyadh
saudi
arabia
introduct
sinc
septemb
report
nearli
case
middl
east
respiratori
syndrom
coronaviru
predominantli
saudi
arabia
therapi
approv
infect
howev
base
limit
data
oral
ribavirin
combin
pegyl
interferon
inject
rif
use
research
question
hypothesi
mortal
rate
clinic
outcom
patient
treat
rif
plu
support
care
versu
support
care
alon
sca
studi
design
retrospect
histor
control
method
chart
data
collect
patient
diagnos
infect
septemb
june
primari
endpoint
death
due
infect
secondari
endpoint
requir
crrt
mechan
ventil
chang
baselin
serum
creatinin
srcr
urea
nitrogen
result
patient
met
studi
inclus
criteria
receiv
rif
sca
rif
group
patient
die
patient
sca
arm
crrt
requir
rif
patient
sca
patient
patient
rif
group
requir
mechan
ventil
patient
sca
averag
rise
srcr
urea
nitrogen
baselin
rif
arm
mgdl
mgdl
respect
respect
sca
arm
respect
conclus
studi
rif
addit
support
care
associ
inferior
clinic
outcom
larger
prospect
studi
warrant
confirm
find
apolog
error
